97 related articles for article (PubMed ID: 7638562)
1. The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum.
Bladbjerg EM; Overgaard K; Gram J; Jespersen J
Scand J Clin Lab Invest; 1995 May; 55(3):267-71. PubMed ID: 7638562
[TBL] [Abstract][Full Text] [Related]
2. Plasma concentrations of blood coagulation factor VII measured by immunochemical and amidolytic methods.
Bladbjerg EM; Gram J; Jespersen J
Scand J Clin Lab Invest; 2000 May; 60(3):161-8. PubMed ID: 10885487
[TBL] [Abstract][Full Text] [Related]
3. Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Moor E; Silveira A; van't Hooft F; Suontaka AM; Eriksson P; Blombäck M; Hamsten A
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):655-64. PubMed ID: 7749878
[TBL] [Abstract][Full Text] [Related]
4. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Scarabin PY; Vissac AM; Kirzin JM; Bourgeat P; Amiral J; Agher R; Guize L
Arterioscler Thromb Vasc Biol; 1996 Sep; 16(9):1170-6. PubMed ID: 8792771
[TBL] [Abstract][Full Text] [Related]
5. Association of factor VII protein concentration with lifestyle factors.
Bladbjerg EM; Møller L; Jespersen J
Scand J Clin Lab Invest; 1998 Jul; 58(4):323-30. PubMed ID: 9741820
[TBL] [Abstract][Full Text] [Related]
6. Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Kario K; Miyata T; Sakata T; Matsuo T; Kato H
Arterioscler Thromb; 1994 Feb; 14(2):265-74. PubMed ID: 8305419
[TBL] [Abstract][Full Text] [Related]
7. Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Carvalho de Sousa J; Bruckert E; Giral P; Soria C; Truffert J; Mirshahi MC; de Gennes JL; Caen JP
Haemostasis; 1989; 19(2):83-90. PubMed ID: 2731779
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphism (Arg353-->Gln) in coagulation factor VII gene and factor VII levels (coagulant activity, antigen and binding ability to tissue factor) in 101 healthy Japanese.
Takamiya O
Scand J Clin Lab Invest; 1995 May; 55(3):211-5. PubMed ID: 7638554
[TBL] [Abstract][Full Text] [Related]
9. Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FVII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study.
Stengård JH; Salomaa V; Rasi V; Vahtera E; Ehnholm C; Krusius T; Perola M; Vartiainen E
Blood Coagul Fibrinolysis; 2001 Sep; 12(6):445-52. PubMed ID: 11555697
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of heparin and tissue factor pathway inhibitor on factor VII assays. possible implications for measurements in vivo after heparin therapy.
Bladbjerg EM; Larsen LF; Ostergaard P; Jespersen J
Blood Coagul Fibrinolysis; 2000 Dec; 11(8):739-45. PubMed ID: 11132652
[TBL] [Abstract][Full Text] [Related]
11. [Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease].
Kang W; Wang H; Xiong L; Wang X; Chu H; Qu B; Liu X; Yin J; Duan B; Yu J; Wang Z
Zhonghua Xue Ye Xue Za Zhi; 2002 Sep; 23(9):457-9. PubMed ID: 12482354
[TBL] [Abstract][Full Text] [Related]
12. Factor VII binding to tissue factor in plasma from warfarin-treated individuals.
Takamiya O; Yoshioka A
Thromb Res; 1996 Mar; 81(6):657-63. PubMed ID: 8868516
[TBL] [Abstract][Full Text] [Related]
13. Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Scharling B; Nielsen GG; Klitgaard T; Skovsted TA; Møss J; Segel S; Larsen LF
Blood Coagul Fibrinolysis; 2007 Oct; 18(7):677-84. PubMed ID: 17890956
[TBL] [Abstract][Full Text] [Related]
14. Canine specific ELISA for coagulation factor VII.
Knudsen T; Kjelgaard-Hansen M; Tranholm M; Wiinberg B; Clausen JT; Hansen JJ; Nichols TC; Kjalke M; Jensen AL; Kristensen AT
Vet J; 2011 Dec; 190(3):352-8. PubMed ID: 21216638
[TBL] [Abstract][Full Text] [Related]
15. Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene.
Sacchi E; Tagliabue L; Scoglio R; Baroncini C; Coppola R; Bernardi F; Mannucci PM
Blood Coagul Fibrinolysis; 1996 Mar; 7(2):114-7. PubMed ID: 8735799
[TBL] [Abstract][Full Text] [Related]
16. Protein C, factor VII and prothrombin time as early markers of liver function recovery or failure after liver transplantation.
Patrassi GM; Sartori MT; Viero M; Boeri G; Simioni P; Bassi N; Piccinni P; Girolami A
Blood Coagul Fibrinolysis; 1993 Dec; 4(6):863-7. PubMed ID: 8148479
[TBL] [Abstract][Full Text] [Related]
17. [Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction].
Xiong SL; Wang Q; Zheng L; Li JL; Wen ZB; He SL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Dec; 27(12):1821-3. PubMed ID: 18158992
[TBL] [Abstract][Full Text] [Related]
18. Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII).
Sanders TA; de Grassi T; Miller GJ; Morrissey JH
Atherosclerosis; 2000 Apr; 149(2):413-20. PubMed ID: 10729392
[TBL] [Abstract][Full Text] [Related]
19. Measurement of hemostatic factors in EDTA plasma.
Green D; McMahon B; Foiles N; Tian L
Am J Clin Pathol; 2008 Nov; 130(5):811-5. PubMed ID: 18854275
[TBL] [Abstract][Full Text] [Related]
20. Thrombin generation measurement in factor VII-depleted plasmas compared to inherited factor VII-deficient plasmas.
Giansily-Blaizot M; Al Dieri R; Schved JF
Pathophysiol Haemost Thromb; 2003; 33(1):36-42. PubMed ID: 12853711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
